Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07280416

Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer

Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer: a Longitudinal Study and Analysis of Associated Factors.

Status
Recruiting
Phase
Study type
Observational
Enrollment
260 (estimated)
Sponsor
Centre Hospitalier Emile Roux · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The diagnosis of cancer can be a major trigger for new sleep problems, especially insomnia, in people who did not have sleep issues before. Insomnia may appear early in the care pathway and can continue over time, often interacting with other physical or emotional symptoms. The main goal of this preliminary study is to describe how insomnia develops during the first months after a cancer diagnosis in patients who had no sleep problems at the time of diagnosis. This will be done through regular follow-up over time. A secondary aim is to identify the factors that may contribute to the onset or persistence of insomnia, such as the cancer treatments patients receive, as well as any medical or non-medical therapies used to manage sleep difficulties. The study will also look at whether patients who develop sleep problems are referred to psychologists trained in specific therapies for insomnia, and how well they follow and adhere to these treatments.

Conditions

Timeline

Start date
2025-12-16
Primary completion
2028-11-01
Completion
2028-11-01
First posted
2025-12-12
Last updated
2026-02-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07280416. Inclusion in this directory is not an endorsement.